Showing results (391-400 of 479) with videos related to
Sort By:
Pageof 48
Investigational New Drugs|February 26, 2014
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancerAlan L Ho, Brynna L Lipson, Eric J Sherman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069V A Miller, F M Benedetti, J R Rigas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic CarcinomaAntoine Desilets, Joris L Vos, Nora Katabi, et al.Annals of Clinical and Laboratory Science|March 18, 2000
Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinaseA Villafania, K Anwar, S Amar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigmDavid G Pfister, Yungpo Bernard Su, Dennis H Kraus, et al.Head & Neck|August 14, 1998
A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neckL B Harrison, A Raben, D G Pfister, et al.Oral Oncology|September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaLara A Dunn, Alan L Ho, Loren S Michel, et al.International Journal of Radiation Oncology, Biology, Physics|August 5, 2008
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experienceStephanie A Terezakis, Kyungmouk S Lee, Ronald A Ghossein, et al.Journal of Pharmacology & Clinical Toxicology|December 27, 2024
A Pharmacokinetic/Toxicodynamic Model of Cisplatin Nephrotoxicity Using the Kidney Injury Molecule-1 BiomarkerLauren E Thompson, Avisek Ghimire, Xia Wen, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 23, 2017
Pre-operative evaluation prior to soft tissue sarcoma excision - Why can't we get it right?N W Mesko, R J Wilson, J M Lawrenz, et al.Pageof 48